Finance

Beta
Lists
4015:TADAWUL
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
SAR 155.40
-0.51%
(-0.80) 1D
Jun 7, 3:18:48 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4015...
Open
SAR 156.00
High
SAR 157.00
Low
SAR 155.00
Mkt. cap
10.88B
Avg. vol.
33.93K
Volume
23.60K
Dividend
2.57%
Quarterly dividend
SAR 1.00
Ex-dividend date
Mar 2, 2026
P/E ratio
22.90
52-wk high
SAR 181.30
52-wk low
SAR 125.00
EPS
SAR 6.79
Shares outstanding
24.18M
No. of employees
1K
Open
SAR 156.00
High
SAR 157.00
Low
SAR 155.00
Mkt. cap
10.88B
Avg. vol.
33.93K
Volume
23.60K
Dividend
2.57%
Quarterly dividend
SAR 1.00
Ex-dividend date
Mar 2, 2026
P/E ratio
22.90
52-wk high
SAR 181.30
52-wk low
SAR 125.00
EPS
SAR 6.79
Shares outstanding
24.18M
No. of employees
1K
News stories
From sources across the web
About Jamjoom Pharmaceuticals Fctry Cmpny SJSC
CEO-
Employees1.13K
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
396.22M
342.31M
304.57M
481.38M
Cost of goods sold
145.43M
133.77M
121.19M
171.00M
Cost of revenue
145.43M
133.77M
121.19M
171.00M
Research and development expenses
8.98M
9.47M
10.86M
9.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.01M
90.86M
110.53M
125.39M
Operating expense
115.45M
98.61M
111.72M
138.01M
Total operating expenses
260.87M
232.38M
232.91M
309.01M
Operating income
135.35M
109.92M
71.66M
172.38M
Other non operating income
-
-
-1.17M
-
EBT including unusual items
139.03M
113.34M
76.91M
174.94M
EBT excluding unusual items
139.03M
113.34M
77.01M
174.94M
Income tax expense
7.01M
6.67M
8.84M
6.73M
Effective tax rate
5.04%
5.89%
11.49%
3.85%
Other operating expenses
-2.54M
-1.72M
-8.56M
3.22M
Net income
132.02M
106.67M
68.07M
168.21M
Net profit margin
33.32%
31.16%
22.35%
34.94%
Earnings per share
-
-
-
-
Interest and investment income
1.44M
991.15K
784.73K
2.32M
Interest expense
-302.42K
-353.59K
-
-1.54M
Net interest expenses
1.14M
637.55K
784.73K
785.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
145.62M
120.95M
82.25M
183.73M
Gain or loss from assets sale
5.00
18.06K
8.39K
34.74K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more